检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:丁慧[1] 禹立霞[1] 凌静娴[2] 刘宝瑞[1] 张葵[3] 王庆飞[3]
机构地区:[1]南京大学医学院附属鼓楼医院肿瘤科,南京市210008 [2]南京大学医学院附属鼓楼医院妇科,南京市210008 [3]南京大学医学院附属鼓楼医院检验科,南京市210008
出 处:《医学分子生物学杂志》2013年第6期318-322,共5页Journal of Medical Molecular Biology
基 金:国家自然科学基金(No.81302241),南京市医学科技发展专项
摘 要:目的建立稳定抑制RPS7基因表达的宫颈癌HeLa细胞株。方法设计并合成靶向人RPS7基因的shRNA寡核苷酸片段,克隆到逆转录病毒载体pSIREN中,构建重组质粒pSIREN-RPS7-shRNA,转染293T细胞,将包装产生的重组逆转录病毒感染宫颈癌HeLa细胞,经嘌呤霉素筛选获得稳定的细胞克隆,用real-timePCR和Western印迹检测细胞中RPS7mRNA和蛋白表达水平。结果获得了经测序鉴定正确的重组逆转录病毒质粒,逆转录病毒感染HeLa细胞后用嘌呤霉素筛选出的稳定细胞中,RPS7mRNA和蛋白水平均显著低于干扰对照细胞。结论成功构建了靶向人RPS7基因的shRNA逆转录病毒载体,建立了稳定抑制RPS7基因表达的宫颈癌HeLa细胞株.为进一步研究RPS7在宫颈癌中的生物学功能和作用机制提供了可靠的细胞模型。Objective human ribosomal protein S7 To establish a HeLa cervical cancer cell line with stable knockdown of gene (RPS7) . Methods shRNA sequences targeting RPS7 were de- signed and cloned into the retrovirus vector pSIREN to obtain the recombinant plasmids pSIREN- RPS7-shRNA. The recombinant plasmids were thereafter transfected into 293T cells for virus pack- age, which was followed by infection of HeLa cells with the packaged virus. Then puromycin was used to generate the stable virus-infected HeLa cells. The RPS7 gene expression level was measured by real-time PCR and Western blotting. Results Recombinant retrovirus shRNA plasmids were cor- rectly constructed as confirmed by sequencing results. RPS7 mRNA and protein levels were signifi- cantly decreased in puromycin-treated pSIREN-RPS7-shRNA- transfected HeLa cells compared with control cells. Conclusions The recombinant retrovirus shRNA vectors targeting RPS7 were success- fully constructed and HeLa cell models with stable knockdown of RPS7 were established, which pro- vide a useful cell line model to further investigate the biological roles of RPS7 and its action mecha- nisms in cervical cancers.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.40